Interaction of ACTH, corticosterone and cyclic nucleotides in harding-passey melanoma malanogenesis
- 1 January 1978
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 261 (3) , 303-309
- https://doi.org/10.1007/bf00455300
Abstract
The acute in vitro action of adrenocorticotropin (ACTH) and corticosterone alone and in combination were determined in the Harding-Passey (HP) melanoma grown in vivo. Hormone treated melanoma dice (5–240 min) were analyzed for tyrosinase activity, cyclic AMP (cAMP) and cyclic GMP (cGMP). ACTH elevated cAMP and cGMP levels 20-and 13-fold, respectively, in the HP melanoma. However, these large increases in cyclic nucleotide levels were accompanied by only a 49% increase in tyrosinase activity. Corticosterone elicited a similar response. ACTH plus corticosterone produced an early cAMP and cGMP peak followed by depression. ACTH plus corticosterone stimulated tyrosinase activity coincident with the early cyclic nucleotide peak followed by a drop in tyrosinase activity which was subsequently elevated. The results indicate that neither cAMP nor cGMP are the sole modulators of tyrosinase activity and suggest the interaction of ACTH, corticosterone and cyclic nucleotides in the regulation of melanoma tyrosinase activity. ACTH und Corticosteron wurden einzeln und in Kombination im Harding-Passey-Melanom in vitro untersucht. Das Melanom war in vivo gewachsen. Die mit den Hormonen behandelten Melanomstücke wurden auf Tyrosinaseaktivität, cyclisches AMP und cyclisches GMP untersucht. ACTH erhöht den cAMP-und cGMP-Spiegel 20-respektiv 13fach im HP-Melanom. Diese Erhöhung der cyclischen Nukleotide wurde aber nur von einem Anstieg der Tyrosinase um 49% begleitet. Corticosterone zeigt keine ähnliche Reaktion. ACTH und Corticosteron entwickelt einen frühen cAMP-und cGMP-Anstieg, dem ein Abfall folgt. ACTH und Corticosteron stimulieren die Tyrosinaseaktivität, gleichzeitig mit dem frühen Anstieg der cyclischen Nukleotide. Danach folgt ein Abfall der Tyronaseaktivität, die aber immerhin noch erhöht darstellbar war. Diese Ergebnisse zeigen, daß weder cAMP noch cGMP die ansteigenden Modulatoren der Tyrosinaseaktivität sind und läßt an eine Interaktion von ACTH, Corticosteron und cyclischen Nukleotiden in der Regulation der Melanomtyrosinaseaktivität denken.This publication has 26 references indexed in Scilit:
- Glucocorticoid Modulation of Adrenocorticotropin-Induced Melanogenesis in the Cloudman S-91 Melanoma in vitroPathobiology, 1978
- Activation of melanoma tyrosinase by a cyclic AMP-dependent protein kinase in a cell-free systemNature, 1977
- In vitro inhibition of cyclic AMP phosphodiesterase by cortisolNature, 1976
- Hormonal specificity of the melanotropin-sensitive adenylate cyclase of mouse melanoma and effect of cyclic amp on the tyrosinase activity of mouse melanoma cells, in vitroBiochimica et Biophysica Acta (BBA) - General Subjects, 1976
- Factors Regulating Growth And Pigmentation Of Melanoma CellsJournal of Investigative Dermatology, 1976
- ACTH control of adrenocortical c-GMPGeneral and Comparative Endocrinology, 1975
- Melanocyte-stimulating hormone promotes activation of pre-existing tyrosinase molecules in Cloudman S91 melanoma cellsNature, 1975
- An Effect of Dexamethasone on Adenosine 3′,5′ -Monophosphate Content and Adenosine 3′,5′ -Monophosphate Phosphodiesterase Activity of Cultured Hepatoma CellsJournal of Clinical Investigation, 1972
- Stimulation of leukocyte adenyl cyclase by hydrocortisone and isoproterenol in asthmatic and nonasthmatic subjectsJournal of Allergy and Clinical Immunology, 1972
- Effects of glucocorticoids and insulin on 3?,5?-AMP phosphodiesterase activity in adrenalectomized ratsDiabetologia, 1968